NNVC

NanoViricides, Inc. NNVC

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NNVC VRCA JSPR SABS GBIO EVAX IGC QTTB MAIA ANTX
6M -6.50 % 40.99 % -69.16 % 113.76 % 57.32 % 94.98 % -6.00 % 101.94 % -15.52 % 3.24 %
YTD -19.01 % 16.93 % -91.68 % 2.56 % -49.68 % 9.31 % -18.38 % -9.28 % -29.67 % -19.78 %
1Y -23.84 % 26.66 % -92.20 % -8.97 % -49.68 % 19.39 % -20.82 % -12.57 % -27.94 % -19.20 %
3Y 1.77 % -66.72 % -69.90 % -41.46 % -85.34 % -94.36 % -5.73 % -84.88 % -54.77 % -87.95 %
5Y -65.57 % -92.95 % -98.27 % -96.25 % -98.37 % -98.98 % -83.25 % -98.59 % -67.04 % -92.76 %
10Y -95.44 % -95.30 % -98.21 % -96.25 % -97.74 % -98.98 % 32.39 % -99.07 % -67.04 % -92.76 %
From the beginning -96.71 % -95.30 % -98.21 % -96.25 % -97.74 % -98.98 % -99.47 % -99.07 % -67.04 % -92.76 %

Dividend

AN2 Therapeutics, Inc.